SHE:300683 - Wuhan Hiteck Biological Pharma Co Ltd

Wuhan Hiteck Biological Pharma
Sector: Health Care, Industry: Pharmaceuticals

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2016 Q1	2016 Q2	2016 Q3	2016 Q4	2017 Q1	2017 Q2	2017 Q3	2017 Q4	2018 Q1	2018 Q2	2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	67.72M -57.1%	166.83M 146.4%	222.31M 33.3%	166.2M -25.2%	221.03M 33.0%	159.41M -27.9%	141.99M -10.9%	138.64M -2.4%	147.81M 6.6%	151.98M 2.8%	163.86M 7.8%	131.89M -19.5%
Cost of Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-3.87M -	65.65M -	128.91M 96.4%	83.3M -35.4%	120.66M 44.9%	81.99M -32.0%	68.92M -15.9%	77.95M 13.1%	86.73M 11.3%	80.05M -7.7%	100.33M 25.3%	79.25M -21.0%
Gross Profit	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	71.59M -14.5%	101.18M 41.3%	93.41M -7.7%	82.9M -11.2%	100.36M 21.1%	77.41M -22.9%	73.07M -5.6%	60.69M -16.9%	61.08M 0.6%	71.93M 17.8%	63.53M -11.7%	52.64M -17.1%
Total Expenses	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	75.42M -48.4%	154.48M 104.8%	230.14M 49.0%	162.4M -29.4%	201.98M 24.4%	169.47M -16.1%	159.46M -5.9%	155.55M -2.5%	172.66M 11.0%	175.34M 1.6%	205.07M 17.0%	184.29M -10.1%
Operating Expense	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	79.29M 10.0%	88.83M 12.0%	101.24M 14.0%	79.09M -21.9%	81.32M 2.8%	87.48M 7.6%	90.54M 3.5%	77.6M -14.3%	85.93M 10.7%	95.3M 10.9%	104.74M 9.9%	105.04M 0.3%
Operating Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-7.7M -	12.35M -	-7.83M -	3.81M -	19.05M 400.1%	-10.07M -	-17.47M -	-16.91M -	-24.85M -	-23.36M -	-41.21M -	-52.4M -
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	5.9M -	-	-	-	25.26M -	-	-	-	-12.82M -	-	-	-
Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-7.31M -	11.42M -	9.02M -21.0%	7.69M -14.7%	11.18M 45.4%	-50.07K -	-32.85M -	-1.47M -	-9.66M -	-15.31M -	-94.38M -	-16.55M -
Basic EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-0.07 -	0.11 -	0.08 -27.3%	0.06 -25.0%	0.09 50%	0 -	-0.26 -	-0.02 -	-0.074 -	-0.12 -	-0.72 -	-0.13 -
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-0.07 -	0.11 -	0.08 -27.3%	0.06 -25.0%	0.09 50%	0 -	-0.26 -	-0.02 -	-0.074 -	-0.12 -	-0.72 -	-0.13 -